Q2 2018 13F Holders as of 6/30/2018
-
Type / Class
-
Equity / Common Stock, par value $0.0001
-
Shares outstanding
-
53M
-
Number of holders
-
51
-
Total 13F shares, excl. options
-
10M
-
Shares change
-
+365K
-
Total reported value, excl. options
-
$217M
-
Value change
-
+$13.9M
-
Number of buys
-
37
-
Number of sells
-
-19
-
Price
-
$21.76
Significant Holders of Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) as of Q2 2018
63 filings reported holding CDLX - Cardlytics, Inc. - Common Stock, par value $0.0001 as of Q2 2018.
Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) has 51 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 10M shares
of 53M outstanding shares and own 18.95% of the company stock.
Largest 10 shareholders include Polaris Venture Management Co. V, L.L.C. (2.64M shares), FMR LLC (1.89M shares), DISCOVERY CAPITAL MANAGEMENT, LLC / CT (1.5M shares), JENNISON ASSOCIATES LLC (806K shares), Voya Investment Management LLC (492K shares), BlackRock Inc. (353K shares), VANGUARD GROUP INC (267K shares), BANK OF AMERICA CORP /DE/ (267K shares), FRONTIER CAPITAL MANAGEMENT CO LLC (228K shares), and WELLINGTON MANAGEMENT GROUP LLP (226K shares).
This table shows the top 51 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.